1. Two novel palbociclib-resorcinol and palbociclib-orcinol cocrystals with enhanced solubility and dissolution rate;Duan;Pharmaceutics,2021
2. Palbociclib: an evidence-based review of its potential in the treatment of breast cancer;Cadoo,2014
3. Palbociclib: first global approval;Dhillon;Drugs,2015
4. Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer;Saren,2023
5. P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclib;De Gooijer;Invest. New Drugs,2015